Skip to content

Clinical trials

Completed Phase 3 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Status: Completed Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20026
20032
20044
20055
20062
20074
20082
20097
20102
20113
20121
20134
20141
20154
20163
20175
20187
20192
20203
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group6
Gynecologic Oncology Group5
Hoffmann-La Roche5
AstraZeneca4
European Organisation for Research and Treatment of Cancer - EORTC4
Medical Research Council4
North Eastern German Society of Gynaecological Oncology4
pharmaand GmbH3
AGO Research GmbH2
ARCAGY/ GINECO GROUP2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms96
Fallopian Tube Neoplasms38
Carcinoma, Ovarian Epithelial33
Peritoneal Neoplasms9
Endometrial Neoplasms7
Breast Neoplasms6
Brenner Tumor6
Neoplasms6
Sarcoma5
Uterine Cervical Neoplasms5

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.